Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125521802 | 12552180 | 2 | F | 20160617 | 20160705 | 20160713 | 20160713 | EXP | GB-WATSON-2016-15287 | ACTAVIS | 62.00 | YR | M | Y | 0.00000 | 20160713 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125521802 | 12552180 | 1 | SS | Carboplatin (Unknown) | CARBOPLATIN | 1 | Unknown | 290 MG, UNKNOWN | U | UNCONFIRMED | 0 | 290 | MG | UNK | |||||
| 125521802 | 12552180 | 2 | PS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 2000 MG, UNKNOWN, INFUSION | U | UNCONFIRMED | 79160 | 2000 | MG | UNK | |||||
| 125521802 | 12552180 | 3 | SS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, UNKNOWN | U | 0 | 6 | MG | |||||||
| 125521802 | 12552180 | 4 | C | CEFALEXIN | CEPHALEXIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 125521802 | 12552180 | 5 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125521802 | 12552180 | 6 | C | DOMPERIDONE | DOMPERIDONE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125521802 | 12552180 | 7 | C | ONDANSETRON | ONDANSETRON | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125521802 | 12552180 | 1 | Product used for unknown indication |
| 125521802 | 12552180 | 2 | Product used for unknown indication |
| 125521802 | 12552180 | 3 | Product used for unknown indication |
| 125521802 | 12552180 | 4 | Product used for unknown indication |
| 125521802 | 12552180 | 5 | Product used for unknown indication |
| 125521802 | 12552180 | 6 | Product used for unknown indication |
| 125521802 | 12552180 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125521802 | 12552180 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125521802 | 12552180 | Abdominal pain lower | |
| 125521802 | 12552180 | Back pain | |
| 125521802 | 12552180 | Body temperature increased | |
| 125521802 | 12552180 | Constipation | |
| 125521802 | 12552180 | Energy increased | |
| 125521802 | 12552180 | Erythema | |
| 125521802 | 12552180 | Eye disorder | |
| 125521802 | 12552180 | Fatigue | |
| 125521802 | 12552180 | Gout | |
| 125521802 | 12552180 | Haemoglobin decreased | |
| 125521802 | 12552180 | Infusion site haemorrhage | |
| 125521802 | 12552180 | Infusion site pain | |
| 125521802 | 12552180 | Infusion site reaction | |
| 125521802 | 12552180 | Mouth ulceration | |
| 125521802 | 12552180 | Myalgia | |
| 125521802 | 12552180 | Neutrophil count decreased | |
| 125521802 | 12552180 | Ocular hyperaemia | |
| 125521802 | 12552180 | Oral pain | |
| 125521802 | 12552180 | Underdose | |
| 125521802 | 12552180 | Urinary tract infection | |
| 125521802 | 12552180 | Vasospasm | |
| 125521802 | 12552180 | Visual impairment | |
| 125521802 | 12552180 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |